Current Opinion in HIV and AIDS

Papers
(The H4-Index of Current Opinion in HIV and AIDS is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The interplay between HIV and COVID-19: summary of the data and responses to date136
Lenacapavir: a first-in-class HIV-1 capsid inhibitor70
Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic46
A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV40
Eliminating HIV reservoirs for a cure: the issue is in the tissue38
Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV33
Frailty: the current challenge for aging people with HIV26
Exosomes in HIV infection26
Cardiovascular toxicity of contemporary antiretroviral therapy25
Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV22
Immunological effector mechanisms in HIV-1 elite controllers21
Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection19
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals19
HIV persistence in lymph nodes19
HIV and cardiovascular disease: the role of inflammation18
Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review17
Technologies for HIV-1 drug resistance testing: inventory and needs17
0.042277097702026